Hellow guys, Welcome to my website, and you are watching Covid-19 Vaccines: Dr. Kathleen Jordan on strategies & pregnant women trials show reassuring results. and this vIdeo is uploaded by Yahoo Finance at 2021-04-22T11:23:23-07:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | Covid-19 Vaccines: Dr. Kathleen Jordan on strategies & pregnant women trials show reassuring results |
| Video Uploader | Video From Yahoo Finance |
| Upload Date | This Video Uploaded At 22-04-2021 18:23:23 |
| Video Discription | Dr. Kathleen Jordan, SVP of Medical Affairs at Tia, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus. #Vaccine #Coronavirus #YahooFinance Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. About Yahoo Finance Premium: With a subscription to Yahoo Finance Premium, get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more. To learn more about Yahoo Finance Premium please visit: https://yhoo.it/33jXYBp Connect with Yahoo Finance: Get the latest news: https://yhoo.it/2fGu5Bb Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP Follow Yahoo Finance on Instagram: http://bit.ly/2LOpNYz Follow Cashay.com Follow Yahoo Finance Premium on Twitter: https://bit.ly/3hhcnmV |
| Category | News & Politics |
| Tags | Yahoo Finance | Personal Finance | Money | Investing | Business | Savings | Investment | Stocks | Bonds | FX | Currencies | NYSE | Equities | News | Politics | Market | Markets | Yahoo FInance Premium | Stock market | Vaccines | coronavirus |
